IOVA icon

Iovance Biotherapeutics

299 hedge funds and large institutions have $1.79B invested in Iovance Biotherapeutics in 2024 Q4 according to their latest regulatory filings, with 58 funds opening new positions, 100 increasing their positions, 84 reducing their positions, and 36 closing their positions.

Holders
299
Holders Change
+16
Holders Change %
+5.65%
% of All Funds
3.98%
Holding in Top 10
7
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-22.22%
% of All Funds
0.09%
New
58
Increased
100
Reduced
84
Closed
36
Calls
$28.9M
Puts
$36.4M
Net Calls
-$7.54M
Net Calls Change
-$27M
Name Market Value Shares Shares
Change
Shares
Change %
DF
326
Dunhill Financial
United Kingdom
-1,100 Closed
CAM
327
Costello Asset Management
Pennsylvania
-300 Closed
VAMG
328
Voisard Asset Management Group
Michigan
-273 Closed
FLPIM
329
F.L. Putnam Investment Management
Massachusetts
-240 Closed
HGA
330
Hobbs Group Advisors
South Carolina
-132 Closed
BTI
331
Blue Trust Inc
Georgia
-91 Closed
CFO
332
CVA Family Office
Colorado
-63 Closed
CPA
333
Capital Performance Advisors
California
-11 Closed
DP
334
Diadema Partners
New Jersey
VU
335
Valence8 US
Massachusetts
BFM
336
Boothbay Fund Management
New York
WVP
337
Worth Venture Partners
New Jersey
Point72 Asset Management
338
Point72 Asset Management
Connecticut
GS
339
GTS Securities
New York
CF
340
Cantor Fitzgerald
New York
CSS
341
Cubist Systematic Strategies
Connecticut
Nomura Asset Management
342
Nomura Asset Management
Japan
Lazard Asset Management
343
Lazard Asset Management
New York
$0 65
CFGS
344
Concourse Financial Group Securities
Alabama
C
345
Covestor
United Kingdom
$0 16 +1 +7%
HWM
346
Hemington Wealth Management
Virginia
$0 13 +4 +44%